VVOS
USDVivos Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.690
Kõrge
$2.690
Madal
$2.600
Maht
0.00M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
16.3M
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
0.12M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and lowers the price target from $6.6 to $6.2.
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31,
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and
Seotud aktsiad
FUNC
First United Corporation
GNT
GAMCO Natural Resources Gold & Income Trust
FULT
Fulton Financial Corporation
ECCF
Eagle Point Credit Company Inc. 8.00% Series F Term Preferred Stock due 2029
SPG
Simon Property Group Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.